{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:47:04Z","timestamp":1782398824799,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00595-025-03213-9","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T06:38:20Z","timestamp":1766385500000},"page":"1092-1104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictive value of neutrophil-to-platelet ratio for postoperative prognosis in distal cholangiocarcinoma: A retrospective study"],"prefix":"10.1007","volume":"56","author":[{"given":"Jun","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zu-yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-wei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-ren","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-cheng","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"3213_CR1","doi-asserted-by":"crossref","unstructured":"Qurashi M, Vithayathil M, Khan SA. Epidemiology of cholangiocarcinoma. Eur J Surg Oncol 2025;51(2):107064.","DOI":"10.1016\/j.ejso.2023.107064"},{"issue":"10272","key":"3213_CR2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","volume":"397","author":"JW Valle","year":"2021","unstructured":"Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX. Biliary tract cancer. Lancet. 2021;397(10272):428\u201344.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"3213_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/liv.14095","volume":"39","author":"SA Khan","year":"2019","unstructured":"Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: epidemiology and risk factors. Liver Int. 2019;39(Suppl 1):19\u201331.","journal-title":"Liver Int"},{"issue":"5","key":"3213_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2022.100737","volume":"27","author":"A Elvevi","year":"2022","unstructured":"Elvevi A, Laffusa A, Scaravaglio M, Rossi RE, Longarini R, Stagno AM, et al. Clinical treatment of cholangiocarcinoma: an updated comprehensive review. Ann Hepatol. 2022;27(5):100737.","journal-title":"Ann Hepatol"},{"issue":"9","key":"3213_CR5","doi-asserted-by":"publisher","first-page":"6674","DOI":"10.3390\/curroncol29090524","volume":"29","author":"L Gorji","year":"2022","unstructured":"Gorji L, Beal EW. Surgical treatment of distal cholangiocarcinoma. Curr Oncol. 2022;29(9):6674\u201387.","journal-title":"Curr Oncol"},{"issue":"4","key":"3213_CR6","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.soc.2019.06.014","volume":"28","author":"RM Lee","year":"2019","unstructured":"Lee RM, Maithel SK. Approaches and outcomes to distal cholangiocarcinoma. Surg Oncol Clin N Am. 2019;28(4):631\u201343.","journal-title":"Surg Oncol Clin N Am"},{"issue":"1","key":"3213_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12885-019-5391-0","volume":"19","author":"PL Labib","year":"2019","unstructured":"Labib PL, Goodchild G, Pereira SP. Molecular pathogenesis of cholangiocarcinoma. BMC Cancer. 2019;19(1):185.","journal-title":"BMC Cancer"},{"key":"3213_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00293","volume":"6","author":"S Roy","year":"2019","unstructured":"Roy S, Glaser S, Chakraborty S. Inflammation and progression of cholangiocarcinoma: role of angiogenic and lymphangiogenic mechanisms. Front Med (Lausanne). 2019;6:293.","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"3213_CR9","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1158\/2326-6066.CIR-21-1101","volume":"10","author":"X Bao","year":"2022","unstructured":"Bao X, Li Q, Chen J, Chen D, Ye C, Dai X, et al. Molecular subgroups of intrahepatic cholangiocarcinoma discovered by single-cell RNA sequencing-assisted multiomics analysis. Cancer Immunol Res. 2022;10(7):811\u201328.","journal-title":"Cancer Immunol Res"},{"issue":"12","key":"3213_CR10","first-page":"6176","volume":"13","author":"R Sturgeon","year":"2023","unstructured":"Sturgeon R, Goel P, Singh RK. Tumor-associated neutrophils in pancreatic cancer progression and metastasis. Am J Cancer Res. 2023;13(12):6176\u201389.","journal-title":"Am J Cancer Res"},{"key":"3213_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194755","author":"W Zheng","year":"2022","unstructured":"Zheng W, Wu J, Peng Y, Sun J, Cheng P, Huang Q. Tumor-associated neutrophils in colorectal cancer development, progression and immunotherapy. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14194755.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"3213_CR12","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1053\/j.gastro.2016.02.040","volume":"150","author":"SL Zhou","year":"2016","unstructured":"Zhou SL, Zhou ZJ, Hu ZQ, Huang XW, Wang Z, Chen EB, et al. Tumor-Associated neutrophils recruit macrophages and T-Regulatory cells to promote progression of hepatocellular carcinoma and resistance to Sorafenib. Gastroenterology. 2016;150(7):1646\u201358.","journal-title":"Gastroenterology"},{"key":"3213_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001946","author":"Z Zhou","year":"2021","unstructured":"Zhou Z, Wang P, Sun R, Li J, Hu Z, Xin H, et al. Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3. J Immunother Cancer. 2021;9(3):e001946. https:\/\/doi.org\/10.1136\/jitc-2020-001946.","journal-title":"J Immunother Cancer"},{"issue":"43","key":"3213_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022827","volume":"99","author":"F Ji","year":"2020","unstructured":"Ji F, Kang Q, Wang L, Liu L, Ke Y, Zhu Y, et al. Prognostic significance of the neutrophil-to-lymphocyte ratio with distal cholangiocarcinoma patients. Medicine (Baltimore). 2020;99(43):e22827.","journal-title":"Medicine (Baltimore)"},{"key":"3213_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1038759","volume":"12","author":"J Li","year":"2022","unstructured":"Li J, Gao L, Liu T, Feng D. Association of systemic inflammation index with survival in patients with advanced perihilar cholangiocarcinoma treated with interventional therapy. Front Oncol. 2022;12:1038759.","journal-title":"Front Oncol"},{"issue":"Suppl 5","key":"3213_CR16","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1245\/s10434-016-5422-x","volume":"23","author":"A Watanabe","year":"2016","unstructured":"Watanabe A, Araki K, Hirai K, Kubo N, Igarashi T, Tsukagoshi M, et al. A novel clinical Factor, D-Dimer platelet Multiplication, May predict postoperative recurrence and prognosis for patients with cholangiocarcinoma. ANN SURG ONCOL. 2016;23(Suppl 5):886\u201391.","journal-title":"ANN SURG ONCOL"},{"issue":"1","key":"3213_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01342-w","volume":"28","author":"L Zhou","year":"2023","unstructured":"Zhou L, Zhang Z, Tian Y, Li Z, Liu Z, Zhu S. The critical role of platelet in cancer progression and metastasis. Eur J Med Res. 2023;28(1):385.","journal-title":"Eur J Med Res"},{"key":"3213_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.1011048","volume":"13","author":"Y Lin","year":"2022","unstructured":"Lin Y, Dai W, Chen Y, He X, Xu Y. Neutrophil-to-platelet ratio predicts mortality following percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction. Front Physiol. 2022;13:1011048.","journal-title":"Front Physiol"},{"issue":"1","key":"3213_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-023-03055-3","volume":"23","author":"Y Li","year":"2023","unstructured":"Li Y, Yang X, Zhou H, Hui X, Li H, Zheng J. A high neutrophil-to-platelet ratio is associated with hematoma expansion in patients with spontaneous intracerebral hemorrhage: a retrospective study. BMC Neurol. 2023;23(1):27.","journal-title":"BMC Neurol"},{"issue":"2","key":"3213_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s00595-022-02539-y","volume":"53","author":"A Nonogaki","year":"2023","unstructured":"Nonogaki A, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, et al. Preoperative neutrophil-to-platelet ratio as a potential prognostic factor for gastric cancer with positive peritoneal lavage cytology in the absence of other non-curative factors: a multi-institutional dataset analysis. Surg Today. 2023;53(2):198\u2013206.","journal-title":"Surg Today"},{"issue":"6","key":"3213_CR21","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jvoice.2020.10.003","volume":"36","author":"B Sahin","year":"2022","unstructured":"Sahin B, Akyol M, Ozel HE, Genc S. Correlation of clinical and pathological diagnosis and inflammatory markers for patients undergoing laryngeal microsurgery. J Voice. 2022;36(6):882\u20139.","journal-title":"J Voice"},{"issue":"1","key":"3213_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11864-023-01153-5","volume":"25","author":"M Wheless","year":"2024","unstructured":"Wheless M, Agarwal R, Goff L, Lockney N, Padmanabhan C, Heumann T. Current standards, multidisciplinary approaches, and future directions in the management of extrahepatic cholangiocarcinoma. Curr Treat Options Oncol. 2024;25(1):127\u201360.","journal-title":"Curr Treat Options Oncol"},{"issue":"8","key":"3213_CR23","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1245\/s10434-021-09811-4","volume":"28","author":"K Sahara","year":"2021","unstructured":"Sahara K, Tsilimigras DI, Toyoda J, Miyake K, Ethun CG, Maithel SK, et al. Defining the risk of early recurrence following curative-intent resection for distal cholangiocarcinoma. Ann Surg Oncol. 2021;28(8):4205\u201313.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"3213_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000499050","volume":"96","author":"S Hoshimoto","year":"2019","unstructured":"Hoshimoto S, Hishinuma S, Shirakawa H, Tomikawa M, Ozawa I, Ogata Y. Association of preoperative platelet-to-lymphocyte ratio with poor outcome in patients with distal cholangiocarcinoma. Oncology. 2019;96(6):290\u20138.","journal-title":"Oncology"},{"issue":"10","key":"3213_CR25","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1007\/s00595-021-02312-7","volume":"51","author":"F Terasaki","year":"2021","unstructured":"Terasaki F, Sugiura T, Okamura Y, Ito T, Yamamoto Y, Ashida R, et al. Systemic immune-inflammation index as a prognostic marker for distal cholangiocarcinoma. Surg Today. 2021;51(10):1602\u20139.","journal-title":"Surg Today"},{"issue":"6","key":"3213_CR26","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1515\/cclm-2016-0527","volume":"55","author":"XB Wei","year":"2017","unstructured":"Wei XB, Liu YH, He PC, Yu DQ, Tan N, Zhou YL, et al. The impact of admission neutrophil-to-platelet ratio on in-hospital and long-term mortality in patients with infective endocarditis. Clinical Chemistry and Laboratory Medicine (CCLM). 2017;55(6):899\u2013906.","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"issue":"5","key":"3213_CR27","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/jso.27806","volume":"130","author":"OP Chatzipanagiotou","year":"2024","unstructured":"Chatzipanagiotou OP, Tsilimigras DI, Catalano G, Ruzzenente A, Aldrighetti L, Weiss M, et al. Preoperative platelet count as an independent predictor of long-term outcomes among patients undergoing resection for intrahepatic cholangiocarcinoma. J Surg Oncol. 2024;130(5):1042\u201350.","journal-title":"J Surg Oncol"},{"issue":"2","key":"3213_CR28","first-page":"987","volume":"38","author":"N Saito","year":"2018","unstructured":"Saito N, Shirai Y, Horiuchi T, Sugano H, Shiba H, Sakamoto T, et al. Preoperative platelet to albumin ratio predicts outcome of patients with cholangiocarcinoma. ANTICANCER RES. 2018;38(2):987\u201392.","journal-title":"ANTICANCER RES"},{"key":"3213_CR29","doi-asserted-by":"crossref","unstructured":"Liu D, Czigany Z, Heij LR, Bouwense S, van Dam R, Lang SA et al. The value of Platelet-to-Lymphocyte ratio as a prognostic marker in cholangiocarcinoma: A systematic review and Meta-Analysis. Cancers (Basel). 2022;14(2):438","DOI":"10.3390\/cancers14020438"},{"issue":"11","key":"3213_CR30","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/jhbp.1058","volume":"29","author":"S Xu","year":"2022","unstructured":"Xu S, Zhang XP, Zhao GD, Zhao ZM, Gao YX, Hu MG, et al. Development and validation of an online calculator to predict early recurrence and long-term survival in patients with distal cholangiocarcinoma after pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci. 2022;29(11):1214\u201325.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"4","key":"3213_CR31","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/jhbp.198","volume":"22","author":"F Miura","year":"2015","unstructured":"Miura F, Sano K, Amano H, Toyota N, Wada K, Yoshida M, et al. Evaluation of portal vein invasion of distal cholangiocarcinoma as borderline resectability. J Hepatobiliary Pancreat Sci. 2015;22(4):294\u2013300.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"4","key":"3213_CR32","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/bjs.9752","volume":"102","author":"M Kiriyama","year":"2015","unstructured":"Kiriyama M, Ebata T, Aoba T, Kaneoka Y, Arai T, Shimizu Y, et al. Prognostic impact of lymph node metastasis in distal cholangiocarcinoma. Br J Surg. 2015;102(4):399\u2013406.","journal-title":"Br J Surg"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-025-03213-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00595-025-03213-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-025-03213-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T13:56:17Z","timestamp":1782395777000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00595-025-03213-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3213"],"URL":"https:\/\/doi.org\/10.1007\/s00595-025-03213-9","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"8 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study complied with the Declaration of Helsinki and was approved by the Ethics Committee of Beijing Chaoyang Hospital (No.2024-D.-511). The requirement of informed consent was waived because of the retrospective study design, which was approved by the appropriate ethics review board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}